SynthesisScientific reports2026
Efficacy and safety signals from early-phase studies of KRAS inhibition in pancreatic cancer.
Kathlen Oliveira Martins Tiede et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this paperpooled itcites it